[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69710111D1 - Behandlung und Prophylaxe von Pankreatitis - Google Patents

Behandlung und Prophylaxe von Pankreatitis

Info

Publication number
DE69710111D1
DE69710111D1 DE69710111T DE69710111T DE69710111D1 DE 69710111 D1 DE69710111 D1 DE 69710111D1 DE 69710111 T DE69710111 T DE 69710111T DE 69710111 T DE69710111 T DE 69710111T DE 69710111 D1 DE69710111 D1 DE 69710111D1
Authority
DE
Germany
Prior art keywords
pancreatitis
treatment
prophylaxis
troglitazone
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69710111T
Other languages
English (en)
Other versions
DE69710111T2 (de
Inventor
Toshihiko Fujiwara
Hiroyoshi Horikoshi
Masaharu Fukami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of DE69710111D1 publication Critical patent/DE69710111D1/de
Application granted granted Critical
Publication of DE69710111T2 publication Critical patent/DE69710111T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Catching Or Destruction (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
DE69710111T 1996-03-18 1997-03-17 Behandlung und Prophylaxe von Pankreatitis Expired - Fee Related DE69710111T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6106396 1996-03-18
JP25020196 1996-09-20

Publications (2)

Publication Number Publication Date
DE69710111D1 true DE69710111D1 (de) 2002-03-14
DE69710111T2 DE69710111T2 (de) 2002-10-02

Family

ID=26402115

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69710111T Expired - Fee Related DE69710111T2 (de) 1996-03-18 1997-03-17 Behandlung und Prophylaxe von Pankreatitis

Country Status (19)

Country Link
US (1) US5753681A (de)
EP (1) EP0796618B1 (de)
KR (1) KR100542778B1 (de)
CN (1) CN1178657C (de)
AT (1) ATE212548T1 (de)
AU (1) AU708315B2 (de)
CA (1) CA2200126C (de)
CZ (1) CZ283968B6 (de)
DE (1) DE69710111T2 (de)
DK (1) DK0796618T3 (de)
ES (1) ES2167678T3 (de)
HK (1) HK1003051A1 (de)
HU (1) HUP9700598A3 (de)
ID (1) ID16266A (de)
IL (1) IL120443A (de)
NO (1) NO313179B1 (de)
NZ (1) NZ314406A (de)
PT (1) PT796618E (de)
TW (1) TW548102B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711683D0 (en) * 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
RU2196141C2 (ru) * 1997-10-08 2003-01-10 Санкио Компани, Лимитед Замещенное конденсированное гетероциклическое соединение, способ фармакологического воздействия, способ ингибирования 5-липоксигеназы, ингибирования продукции липидных пероксидов или снижения уровня сахара в крови
ATE258931T1 (de) * 1998-03-30 2004-02-15 Japan Tobacco Inc Verfahren zur herstellung einer isooxazolidindion-verbindung
US7045519B2 (en) * 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
DE69919707T2 (de) 1998-06-19 2005-09-01 Chiron Corp., Emeryville Glycogen synthase kinase 3 inhibitoren
KR20010079551A (ko) * 1998-07-21 2001-08-22 피터 기딩스 아폽토시스를 감소시키기 위한 글루코즈 업테이크증진제의 용도
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
WO2001000223A2 (en) * 1999-06-25 2001-01-04 Minimed Inc. Multiple agent diabetes therapy
ATE296815T1 (de) 1999-08-23 2005-06-15 Kyorin Seiyaku Kk Substituierte benzylthiazolidin-2,4-dion derivate
WO2001014349A1 (fr) 1999-08-23 2001-03-01 Kyorin Pharmaceutical Co., Ltd. Derives de benzylthiazolidine-2,4-dione substitues
US6452014B1 (en) * 2000-12-22 2002-09-17 Geron Corporation Telomerase inhibitors and methods of their use
WO2002067969A2 (en) 2001-02-21 2002-09-06 Medtronic Minimed, Inc. Stabilized insulin formulations
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
MA33248B1 (fr) 2009-04-01 2012-05-02 Genentech Inc Traitement de troubles résistant à l'insuline

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
DE3343141A1 (de) * 1983-11-29 1985-06-05 Hermann P.T. 7400 Tübingen Ammon Verwendung von cystein-derivaten oder deren salzen, zur steigerung der insulinsekretion der langerhans'schen inseln der bauchspeicheldruese
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
WO1986007056A1 (en) * 1985-05-21 1986-12-04 Pfizer Inc. Hypoglycemic thiazolidinediones
US5232925A (en) * 1987-09-04 1993-08-03 Beecham Group P.L.C. Compounds
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group P.L.C., Brentford Substituierte Thiazolidindionderivate
US5194443A (en) * 1987-09-04 1993-03-16 Beecham Group P.L.C. Compounds
US5260445A (en) * 1987-09-04 1993-11-09 Beecham Group P.L.C. 2,4-thiazolidinediones
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
ZA895838B (en) * 1988-08-18 1991-03-27 Syntex Inc Pharmaceutical compounds
JP2845743B2 (ja) * 1992-12-28 1999-01-13 三菱化学株式会社 新規なナフタレン誘導体
AU7118694A (en) * 1993-07-13 1995-02-13 Janica M. Moizis Fastener for clothing
DK0684242T3 (da) * 1993-12-27 1999-11-01 Japan Tobacco Inc Isoxazolidindionderivat og anvendelse deraf
CA2146701A1 (en) * 1994-04-11 1995-10-12 Takashi Fujita Heterocyclic compounds having anti-diabetic activity, their preparation and their use
US5594015A (en) * 1994-06-22 1997-01-14 Regents Of The University Of California Thiazolidine derivatives for the treatment of psoriasis
FR2721608B1 (fr) * 1994-06-22 1996-07-19 Rhone Poulenc Rorer Sa Dérivés de thiazolidine, leur préparation et les médicaments les contenant.
CA2159938A1 (en) * 1994-10-07 1996-04-08 Hiroaki Yanagisawa Oxime derivatives, their preparation and their therapeutic use
CZ293016B6 (cs) * 1995-06-01 2004-01-14 Sankyo Company Limited Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem

Also Published As

Publication number Publication date
NO971219L (no) 1997-09-19
NO313179B1 (no) 2002-08-26
ATE212548T1 (de) 2002-02-15
AU708315B2 (en) 1999-07-29
HK1003051A1 (en) 1998-10-09
CZ79097A3 (en) 1997-10-15
KR19980023975A (ko) 1998-07-06
NO971219D0 (no) 1997-03-17
EP0796618B1 (de) 2002-01-30
IL120443A (en) 2000-07-16
US5753681A (en) 1998-05-19
ID16266A (id) 1997-09-18
EP0796618A1 (de) 1997-09-24
CN1170575A (zh) 1998-01-21
TW548102B (en) 2003-08-21
HUP9700598A2 (hu) 1998-09-28
HUP9700598A3 (en) 1998-10-28
IL120443A0 (en) 1997-07-13
MX9702058A (es) 1998-03-31
CA2200126C (en) 2006-08-15
NZ314406A (en) 2000-12-22
ES2167678T3 (es) 2002-05-16
PT796618E (pt) 2002-06-28
AU1628597A (en) 1997-09-25
DK0796618T3 (da) 2002-05-06
CZ283968B6 (cs) 1998-07-15
HU9700598D0 (en) 1997-05-28
DE69710111T2 (de) 2002-10-02
CN1178657C (zh) 2004-12-08
CA2200126A1 (en) 1997-09-18
KR100542778B1 (ko) 2006-04-14

Similar Documents

Publication Publication Date Title
ATE212548T1 (de) Behandlung und prophylaxe von pankreatitis
ATE425750T1 (de) Verwendung von triglyceriden mit mittellangen ketten zur behandlung und vorbeugung der alzheimerschen erkrankung
PL304649A1 (en) Novel derivatives of taxane and pharmaceutical agents
DE69431056D1 (de) Substituierte oxazolyl-derivate zur behandlung von entzündungen
LU91271I2 (fr) Natalizumab et ses dérivés pharmaceutiquement acceptables (TYSABRI)
DK0842934T3 (da) 5-HT1F agonister
FI890311A (fi) Kemiska foereningar.
ATE224714T1 (de) Behandlung von tinnitus mit neuroprotektiven wirkstoffen
ES2127396T3 (es) Inhibidores aromaticos de acetilcolinesterasa.
DE69825605D1 (de) Behandlung der schizophrenie und der psychose
DE69827387D1 (de) Verwendung von pramipexol zur behandlung von restless-legs-syndrom
NO943765L (no) Aryloksybenzen-herbicidmidler
ATE222255T1 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel
ATE269714T1 (de) Tcf-ii für vorbeugung und/oder behandlung von strahlungsinduzierter störungen
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia
ATE292970T1 (de) Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden
DK0810223T3 (da) Adamantylsubstituerede oxindoler som farmaceutiske midler
DE69822628D1 (de) Zur vorbeugung oder behandlung von östrogenabhängigen krankheiten nützliche pyrrolo[2.1.5-cd]indolizin-derivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee